242 related articles for article (PubMed ID: 19744531)
1. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy.
Lehto T; Abes R; Oskolkov N; Suhorutsenko J; Copolovici DM; Mäger I; Viola JR; Simonson OE; Ezzat K; Guterstam P; Eriste E; Smith CI; Lebleu B; Samir El Andaloussi ; Langel U
J Control Release; 2010 Jan; 141(1):42-51. PubMed ID: 19744531
[TBL] [Abstract][Full Text] [Related]
2. A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy.
Mäe M; El Andaloussi S; Lundin P; Oskolkov N; Johansson HJ; Guterstam P; Langel U
J Control Release; 2009 Mar; 134(3):221-7. PubMed ID: 19105971
[TBL] [Abstract][Full Text] [Related]
3. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
[TBL] [Abstract][Full Text] [Related]
4. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.
Andaloussi SE; Lehto T; Lundin P; Langel U
Methods Mol Biol; 2011; 683():361-73. PubMed ID: 21053143
[TBL] [Abstract][Full Text] [Related]
5. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
Abes S; Moulton HM; Clair P; Prevot P; Youngblood DS; Wu RP; Iversen PL; Lebleu B
J Control Release; 2006 Dec; 116(3):304-13. PubMed ID: 17097177
[TBL] [Abstract][Full Text] [Related]
6. Induction of splice correction by cell-penetrating peptide nucleic acids.
El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
[TBL] [Abstract][Full Text] [Related]
7. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.
Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG
ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166
[TBL] [Abstract][Full Text] [Related]
8. Stearylated antimicrobial peptide melittin and its retro isomer for efficient gene transfection.
Zhang W; Song J; Liang R; Zheng X; Chen J; Li G; Zhang B; Yan X; Wang R
Bioconjug Chem; 2013 Nov; 24(11):1805-12. PubMed ID: 24107137
[TBL] [Abstract][Full Text] [Related]
9. New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids.
Arukuusk P; Pärnaste L; Oskolkov N; Copolovici DM; Margus H; Padari K; Möll K; Maslovskaja J; Tegova R; Kivi G; Tover A; Pooga M; Ustav M; Langel U
Biochim Biophys Acta; 2013 May; 1828(5):1365-73. PubMed ID: 23357356
[TBL] [Abstract][Full Text] [Related]
10. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of improved gene transfer by the N-terminal stearylation of octaarginine: enhanced cellular association by hydrophobic core formation.
Khalil IA; Futaki S; Niwa M; Baba Y; Kaji N; Kamiya H; Harashima H
Gene Ther; 2004 Apr; 11(7):636-44. PubMed ID: 14973542
[TBL] [Abstract][Full Text] [Related]
12. Peptide-mediated delivery of nucleic acids into mammalian cells.
Deshayes S; Simeoni F; Morris MC; Divita G; Heitz F
Methods Mol Biol; 2007; 386():299-308. PubMed ID: 18604951
[TBL] [Abstract][Full Text] [Related]
13. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
Suhorutsenko J; Oskolkov N; Arukuusk P; Kurrikoff K; Eriste E; Copolovici DM; Langel U
Bioconjug Chem; 2011 Nov; 22(11):2255-62. PubMed ID: 21978260
[TBL] [Abstract][Full Text] [Related]
14. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
Deshayes S; Morris M; Heitz F; Divita G
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
[TBL] [Abstract][Full Text] [Related]
15. Chemokine-derived peptides as carriers for gene delivery to CXCR4 expressing cells.
Egorova A; Kiselev A; Hakli M; Ruponen M; Baranov V; Urtti A
J Gene Med; 2009 Sep; 11(9):772-81. PubMed ID: 19562713
[TBL] [Abstract][Full Text] [Related]
16. Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides.
Wolf Y; Pritz S; Abes S; Bienert M; Lebleu B; Oehlke J
Biochemistry; 2006 Dec; 45(50):14944-54. PubMed ID: 17154532
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
Guterstam P; Andaloussi SE; Langel U
Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer by adenovirus-mimetic peptides in the presence of a cationic lipid and/or adenovirus. Analysis of the contribution of the viral and nonviral components.
Moritz S; Colin M; Keller M; Klonjkowski B; Capeau J; Coutelle C; Chroboczek J; Brahimi-Horn MC
Arch Virol; 2003 Jan; 148(1):1-18. PubMed ID: 12536292
[TBL] [Abstract][Full Text] [Related]
19. Formulation and delivery of splice-correction antisense oligonucleotides by amino acid modified polyethylenimine.
Zaghloul EM; Viola JR; Zuber G; Smith CI; Lundin KE
Mol Pharm; 2010 Jun; 7(3):652-63. PubMed ID: 20128628
[TBL] [Abstract][Full Text] [Related]
20. Splice-switching efficiency and specificity for oligonucleotides with locked nucleic acid monomers.
Guterstam P; Lindgren M; Johansson H; Tedebark U; Wengel J; El Andaloussi S; Langel U
Biochem J; 2008 Jun; 412(2):307-13. PubMed ID: 18271753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]